BFRI News and Press, Biofrontera Inc.

2024-05-16 14:44:07 ET Biofrontera Inc. (BFRI) Q1 2024 Earnings Conference Call May 16, 2024, 10:00 AM ET Company Participants Andrew Barwicki - Barwicki Investor Relations Hermann Luebbert - Chief Executive Officer, Chairman and Founder Fred Leffler - Chief Fina...

2024-05-15 17:46:15 ET More on Biofrontera Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript Biofrontera stock soars on announcing private placement of up to $16M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofronte...

Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results f...

Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...

2024-05-10 10:00:27 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

2024-05-10 08:30:00 ET More on pre-market losers & stocks. Inotiv Stock: Financial Turnaround Overshadowed By Animal Testing Controversies Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript Biofrontera stock soars on announcing private placement of up to $1...

2024-05-03 13:11:27 ET More on Biofrontera Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript Biofrontera stock soars on announcing private placement of up to $16M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofronte...

WOBURN MA / ACCESSWIRE / May 3, 2024 / WOBURN, MA / ACCESSWIRE / May 3, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company") , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that the Board of Directors has met and certified that tw...

WOBURN, MA / ACCESSWIRE / March 26, 2024 / Biofrontera, Inc. (NASDAQ:BFRI) (the "Company") , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that its 2024 Annual Meeting of Stockholders will be held on June 12, 2024 and that the close ...

2024-03-18 12:13:02 ET Biofrontera Inc. (BFRI) Q4 2023 Earnings Conference Call March 18, 2024, 10:00 AM ET Company Participants Andrew Barwicki - Barwicki Investor Relations Hermann Luebbert - Chief Executive Officer, Chairman & Founder Fred Leffler - Chief ...